Long-Term Tofersen Use May Slow ALS Progression, 3-Year Data Suggest

(MedPage Today) — Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic lateral sclerosis (ALS) compared with delayed treatment, according to data from the VALOR trial and its open…

Source link : https://www.medpagetoday.com/neurology/generalneurology/119165

Author :

Publish date : 2025-12-23 17:46:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Long-Term Tofersen Use May Slow ALS Progression, 3-Year Data Suggest

‘Armored’ CAR T Cells Show Early Promise in Relapsed B-Cell ALL

Six-Monthly HIV Prevention Injection Cleared by MHRA

Related Posts

Trump Talks About Taking GLP-1s; New MiniMed System OK’d; Testosterone in Diet Recs

The New Dietary Guidelines Serve Up a Muddled Mix of Ideology and Science

Is Dry January a good thing?

Spine Fractures to Be Flagged During Routine DEXA Scans

The Pacific Islanders fighting to save their homes from climate catastrophe

Critical incident declared at Nottingham University Hospitals NHS Trust

Trump Talks About Taking GLP-1s; New MiniMed System OK’d; Testosterone in Diet Recs

The New Dietary Guidelines Serve Up a Muddled Mix of Ideology and Science

Is Dry January a good thing?

Spine Fractures to Be Flagged During Routine DEXA Scans

The Pacific Islanders fighting to save their homes from climate catastrophe

Critical incident declared at Nottingham University Hospitals NHS Trust

Chocolate Recalled Nationwide; Testosterone Diet Guidance; Autistic Barbie Launched

How to spot illicit cigarettes

Categories

Archives